NOV 17, 202655 MINS READ
Acetyl Hexapeptide-8 (CAS 616204-22-9, molecular formula C₃₄H₆₀N₁₄O₁₂S, molecular weight 888.91 Da) is a linear hexapeptide comprising the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂ 1. The peptide's architecture integrates multiple functional groups that collectively govern its physicochemical behavior, synthetic accessibility, and biological performance. The N-terminus is capped with an acetyl group (–COCH₃), which eliminates the free amino group and imparts lipophilicity while preventing enzymatic degradation by aminopeptidases 3. The C-terminus is amidated (–CONH₂), a modification that enhances metabolic stability by blocking carboxypeptidase cleavage and improves receptor affinity 4. Between these termini, the peptide backbone contains six amino acid residues, each contributing distinct side-chain functionalities:
The peptide's overall charge at pH 5.5–6.5 (typical cosmetic formulation range) is approximately +1 to +2, balancing the two anionic Glu residues against the two cationic Arg residues and the neutral acetyl/amide termini 9. This amphipathic character—hydrophilic charged residues flanking a central hydrophobic Met—facilitates interaction with both aqueous and lipid environments, a prerequisite for transdermal penetration 7,12.
The acetyl moiety (CH₃CO–) at the N-terminus is introduced via acetylation of the terminal amino group, typically using acetic anhydride or acetyl chloride in organic solvents such as pyridine or dichloromethane during solid-phase peptide synthesis (SPPS) 3,4,6. This modification serves three critical functions:
Analytical characterization of the acetyl group is routinely performed by high-performance liquid chromatography–mass spectrometry (HPLC-MS), where the intact peptide exhibits a molecular ion [M+H]⁺ at m/z 889.4, and fragmentation patterns confirm the presence of the N-terminal Ac-Glu residue 5. Infrared (IR) spectroscopy reveals a characteristic carbonyl stretch at ~1650 cm⁻¹, distinct from the amide I band of the peptide backbone 6.
The two γ-carboxyl groups of Glu¹ and Glu² are weak acids (pKa ~4.2) that exist predominantly as carboxylate anions (–COO⁻) at pH >5 9. These groups contribute to:
However, the carboxyl groups also pose formulation challenges. In acidic environments (pH <4), protonation reduces solubility and may trigger aggregation or precipitation 9. Patent CN113398236B 9 addresses this by incorporating fruit acid derivatives (glycolic acid, citric acid, lactic acid, or their sodium salts) at 1.0–5.0 wt% to buffer the formulation to pH 4.5–6.5, maintaining carboxylate ionization and preventing peptide crystallization. Stability studies demonstrated that formulations with citric acid retained >85% peptide content after 6 months at 45°C, compared to <70% in unbuffered controls 9.
The thioether sulfur (–S–) in Met³ is highly susceptible to oxidation by reactive oxygen species (ROS), peroxides, or atmospheric oxygen, yielding methionine sulfoxide (MetO) or, under harsher conditions, methionine sulfone (MetO₂) 5,14. Oxidation at Met³ disrupts the peptide's three-dimensional structure and abolishes its ability to inhibit SNARE complex formation, thereby eliminating anti-wrinkle efficacy 5. Analytical methods to quantify Met oxidation include:
To mitigate oxidation, several strategies have been developed:
The primary amide (–CONH₂) of Gln⁴ undergoes deamidation via nucleophilic attack by the backbone nitrogen of the succeeding residue (Arg⁵), forming a cyclic imide intermediate that hydrolyzes to a mixture of glutamic acid and iso-glutamic acid 14. Deamidation is accelerated by:
Patent CN116925152A 14 specifies that related peptide impurities (including deamidated species) must not exceed 2.0% for batch release, and recommends storage at ≤25°C and pH 5.0–6.0 to minimize deamidation 14. Analytical detection employs RP-HPLC with UV detection at 214 nm, where deamidated peptides elute slightly earlier due to the introduction of a carboxyl group 5.
The two guanidinium moieties (–C(=NH)–NH₂⁺) of Arg⁵ and Arg⁶ remain fully protonated across pH 2–12, conferring a persistent +2 charge that drives multiple biological and formulation phenomena 2,7:
The C-terminal amide (–CONH₂) is introduced by cleaving the peptide from a Rink Amide resin during SPPS, or by enzymatic amidation using peptidylglycine α-amidating monooxygenase (PAM) in biosynthetic routes 4,16. This modification:
Analytical confirmation of C-terminal amidation is achieved by tandem mass spectrometry (MS/MS), where fragmentation of the [M+H]⁺ ion yields a characteristic y₁ fragment at m/z 175.1 (Arg-NH₂) 5.
The majority of acetyl hexapeptide-8 production employs Fmoc-based SPPS on Rink Amide resin, which directly yields the C-terminal amide upon cleavage 4,6. The synthesis proceeds as follows:
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| 浙江湃肽生物有限公司南京分公司 | Quality control and analytical testing of acetyl hexapeptide-8 raw materials in cosmetic manufacturing, particularly for monitoring carboxyl, thioether, and guanidinium functional groups. | Acetyl Hexapeptide-8 Detection Kit | Pre-column derivatization with amino-derivative reagents (dimethyl-imidazo-pyridinyl-methanol or dimethoxymethyl-furano-pyridinyl-methanol) combined with HPLC analysis achieves excellent detection sensitivity, accuracy and repeatability for acetyl hexapeptide-8 functional group characterization. |
| 杭州信海医药科技有限公司 | Large-scale solid-phase peptide synthesis for cosmetic active ingredient production, ensuring functional group integrity during acetylation and amidation steps. | Acetyl Hexapeptide-8 SPPS Synthesis Platform | Utilizes modified N-hydroxyphthalimide (p-dimethylquinone-modified HOBt) as condensing agent with DIC, achieving >99% coupling efficiency per cycle and high-purity acetyl hexapeptide-8 with intact N-terminal acetyl and C-terminal amide functional groups. |
| 陕西慧康生物科技有限责任公司 | Anti-wrinkle facial serums and eye creams requiring high peptide concentration with stabilized functional groups (carboxyl, thioether, guanidinium) for extended shelf life. | High-Content Acetyl Hexapeptide-8 Transparent Cosmetic Serum | Incorporates 3.0-15.0 wt% acetyl hexapeptide-8 with fruit acid derivatives (1.0-5.0 wt%) and polysaccharide polymers (0.1-2.0 wt%) at pH 4.5-6.5, maintaining carboxyl group ionization and preventing methionine oxidation, retaining >85% peptide content after 6 months at 45°C. |
| SHENZHEN READLINE BIOTECHNOLOGY CO. LTD. | Oil-based anti-aging cosmetics and lipophilic delivery systems requiring enhanced protection of methionine thioether and other reactive functional groups against oxidation. | Acetyl Hexapeptide-8 Crystal Polymorphs (C, D, E) | Novel crystal forms C, D, and E exhibit superior oxidative stability of methionine thioether group compared to lyophilized powder, with oil-soluble formulations retaining 80-85% peptide content at 45°C versus 65-70% for conventional forms. |
| 汉肽生物医药集团有限公司 | Industrial-scale production of acetyl hexapeptide-8 for cosmetic applications, with optimized protection and deprotection of multiple functional groups in sequential coupling reactions. | Liquid-Phase Acetyl Hexapeptide-8 Synthesis System | Employs liquid-phase 2+2+2 strategy synthesizing three dipeptide monomers (Ac-Glu-Glu-OH, H-Met-Gln-OH, H-Arg-Arg-NH2) with protected functional groups (tBu for carboxyl, Trt for amide, Pbf for guanidinium), expanding synthesis scale while reducing organic solvent consumption. |